1h Free Analyst Time
The hospital infection therapeutics market is forecasted to grow by $3106.6 mn during 2022-2027, accelerating at a CAGR of 4.98% during the forecast period. The report on the hospital infection therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in incidence and prevalence of respiratory disorders, growing geriatric population, and special drug designations.
The hospital infection therapeutics market is segmented as below:
By Drug Class
- Antibiotics drugs
- Antifungal drugs
- Antiviral drugs
By Type
- Respiratory tract infections
- Surgical site infections
- Bloodstream infections
- Gastrointestinal infections
- Urinary tract infections
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the hospital infection therapeutics market covers the following areas:
- Hospital infection therapeutics market sizing
- Hospital infection therapeutics market forecast
- Hospital infection therapeutics market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global hospital infection therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global hospital infection therapeutics market 2017 - 2021 ($ million)
4.2 Drug Class Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Drug Class
6.1 Market segments
Exhibit 30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibit 31: Data Table on Drug Class - Market share 2022-2027 (%)
6.2 Comparison by Drug Class
Exhibit 32: Chart on Comparison by Drug Class
Exhibit 33: Data Table on Comparison by Drug Class
6.3 Antibiotics drugs - Market size and forecast 2022-2027
Exhibit 34: Chart on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
6.4 Antifungal drugs - Market size and forecast 2022-2027
Exhibit 38: Chart on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Antifungal drugs - Year-over-year growth 2022-2027 (%)
6.5 Antiviral drugs - Market size and forecast 2022-2027
Exhibit 42: Chart on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Antiviral drugs - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Drug Class
Exhibit 46: Market opportunity by Drug Class ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 47: Chart on Type - Market share 2022-2027 (%)
Exhibit 48: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 49: Chart on Comparison by Type
Exhibit 50: Data Table on Comparison by Type
7.3 Respiratory tract infections - Market size and forecast 2022-2027
Exhibit 51: Chart on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
7.4 Surgical site infections - Market size and forecast 2022-2027
Exhibit 55: Chart on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Surgical site infections - Year-over-year growth 2022-2027 (%)
7.5 Bloodstream infections - Market size and forecast 2022-2027
Exhibit 59: Chart on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibit 60: Data Table on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Chart on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibit 62: Data Table on Bloodstream infections - Year-over-year growth 2022-2027 (%)
7.6 Gastrointestinal infections - Market size and forecast 2022-2027
Exhibit 63: Chart on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
7.7 Urinary tract infections - Market size and forecast 2022-2027
Exhibit 67: Chart on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Urinary tract infections - Year-over-year growth 2022-2027 (%)
7.8 Market opportunity by Type
Exhibit 71: Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 73: Chart on Market share by geography 2022-2027 (%)
Exhibit 74: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 75: Chart on Geographic comparison
Exhibit 76: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 105: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 107: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 108: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 109: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 110: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 111: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 112: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 113: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 114: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 116: Overview on factors of disruption
11.4 Industry risks
Exhibit 117: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 118: Vendors covered
12.2 Market positioning of vendors
Exhibit 119: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 120: Abbott Laboratories - Overview
Exhibit 121: Abbott Laboratories - Business segments
Exhibit 122: Abbott Laboratories - Key news
Exhibit 123: Abbott Laboratories - Key offerings
Exhibit 124: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 125: AbbVie Inc. - Overview
Exhibit 126: AbbVie Inc. - Product/Service
Exhibit 127: AbbVie Inc. - Key news
Exhibit 128: AbbVie Inc. - Key offerings
12.5 Achilles Therapeutics plc
Exhibit 129: Achilles Therapeutics plc - Overview
Exhibit 130: Achilles Therapeutics plc - Product/Service
Exhibit 131: Achilles Therapeutics plc - Key offerings
12.6 AstraZeneca Plc
Exhibit 132: AstraZeneca Plc - Overview
Exhibit 133: AstraZeneca Plc - Product/Service
Exhibit 134: AstraZeneca Plc - Key news
Exhibit 135: AstraZeneca Plc - Key offerings
12.7 Bayer AG
Exhibit 136: Bayer AG - Overview
Exhibit 137: Bayer AG - Business segments
Exhibit 138: Bayer AG - Key news
Exhibit 139: Bayer AG - Key offerings
Exhibit 140: Bayer AG - Segment focus
12.8 Bristol Myers Squibb Co.
Exhibit 141: Bristol Myers Squibb Co. - Overview
Exhibit 142: Bristol Myers Squibb Co. - Product/Service
Exhibit 143: Bristol Myers Squibb Co. - Key news
Exhibit 144: Bristol Myers Squibb Co. - Key offerings
12.9 F. Hoffmann La Roche Ltd.
Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
12.10 Gilead Sciences Inc.
Exhibit 150: Gilead Sciences Inc. - Overview
Exhibit 151: Gilead Sciences Inc. - Product/Service
Exhibit 152: Gilead Sciences Inc. - Key news
Exhibit 153: Gilead Sciences Inc. - Key offerings
12.11 GlaxoSmithKline Plc
Exhibit 154: GlaxoSmithKline Plc - Overview
Exhibit 155: GlaxoSmithKline Plc - Business segments
Exhibit 156: GlaxoSmithKline Plc - Key offerings
Exhibit 157: GlaxoSmithKline Plc - Segment focus
12.12 Johnson and Johnson
Exhibit 158: Johnson and Johnson - Overview
Exhibit 159: Johnson and Johnson - Business segments
Exhibit 160: Johnson and Johnson - Key news
Exhibit 161: Johnson and Johnson - Key offerings
Exhibit 162: Johnson and Johnson - Segment focus
12.13 Merck and Co. Inc.
Exhibit 163: Merck and Co. Inc. - Overview
Exhibit 164: Merck and Co. Inc. - Business segments
Exhibit 165: Merck and Co. Inc. - Key news
Exhibit 166: Merck and Co. Inc. - Key offerings
Exhibit 167: Merck and Co. Inc. - Segment focus
12.14 Novartis AG
Exhibit 168: Novartis AG - Overview
Exhibit 169: Novartis AG - Business segments
Exhibit 170: Novartis AG - Key offerings
Exhibit 171: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 172: Pfizer Inc. - Overview
Exhibit 173: Pfizer Inc. - Product/Service
Exhibit 174: Pfizer Inc. - Key news
Exhibit 175: Pfizer Inc. - Key offerings
12.16 Sanofi SA
Exhibit 176: Sanofi SA - Overview
Exhibit 177: Sanofi SA - Business segments
Exhibit 178: Sanofi SA - Key news
Exhibit 179: Sanofi SA - Key offerings
Exhibit 180: Sanofi SA - Segment focus
12.17 Viatris Inc.
Exhibit 181: Viatris Inc. - Overview
Exhibit 182: Viatris Inc. - Business segments
Exhibit 183: Viatris Inc. - Key offerings
Exhibit 184: Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 185: Inclusions checklist
Exhibit 186: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 187: Currency conversion rates for US$
13.4 Research methodology
Exhibit 188: Research methodology
Exhibit 189: Validation techniques employed for market sizing
Exhibit 190: Information sources
13.5 List of abbreviations
Exhibit 191: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global hospital infection therapeutics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Drug Class Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Drug Class - Market share 2022-2027 (%)
Exhibits 31: Data Table on Drug Class - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Drug Class
Exhibits 33: Data Table on Comparison by Drug Class
Exhibits 34: Chart on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Antibiotics drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Antibiotics drugs - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Antifungal drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Antifungal drugs - Year-over-year growth 2022-2027 (%)
Exhibits 42: Chart on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 43: Data Table on Antiviral drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 44: Chart on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 45: Data Table on Antiviral drugs - Year-over-year growth 2022-2027 (%)
Exhibits 46: Market opportunity by Drug Class ($ million)
Exhibits 47: Chart on Type - Market share 2022-2027 (%)
Exhibits 48: Data Table on Type - Market share 2022-2027 (%)
Exhibits 49: Chart on Comparison by Type
Exhibits 50: Data Table on Comparison by Type
Exhibits 51: Chart on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Respiratory tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Respiratory tract infections - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Surgical site infections - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Surgical site infections - Year-over-year growth 2022-2027 (%)
Exhibits 59: Chart on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibits 60: Data Table on Bloodstream infections - Market size and forecast 2022-2027 ($ million)
Exhibits 61: Chart on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibits 62: Data Table on Bloodstream infections - Year-over-year growth 2022-2027 (%)
Exhibits 63: Chart on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibits 64: Data Table on Gastrointestinal infections - Market size and forecast 2022-2027 ($ million)
Exhibits 65: Chart on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibits 66: Data Table on Gastrointestinal infections - Year-over-year growth 2022-2027 (%)
Exhibits 67: Chart on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits 68: Data Table on Urinary tract infections - Market size and forecast 2022-2027 ($ million)
Exhibits 69: Chart on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibits 70: Data Table on Urinary tract infections - Year-over-year growth 2022-2027 (%)
Exhibits 71: Market opportunity by Type ($ million)
Exhibits 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 73: Chart on Market share by geography 2022-2027 (%)
Exhibits 74: Data Table on Market share by geography 2022-2027 (%)
Exhibits 75: Chart on Geographic comparison
Exhibits 76: Data Table on Geographic comparison
Exhibits 77: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits 101: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 103: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 104: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 105: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 106: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 107: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 108: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 109: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 110: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 111: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 112: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 113: Market opportunity by geography ($ million)
Exhibits 114: Impact of drivers and challenges in 2022 and 2027
Exhibits 115: Overview on Criticality of inputs and Factors of differentiation
Exhibits 116: Overview on factors of disruption
Exhibits 117: Impact of key risks on business
Exhibits 118: Vendors covered
Exhibits 119: Matrix on vendor position and classification
Exhibits 120: Abbott Laboratories - Overview
Exhibits 121: Abbott Laboratories - Business segments
Exhibits 122: Abbott Laboratories - Key news
Exhibits 123: Abbott Laboratories - Key offerings
Exhibits 124: Abbott Laboratories - Segment focus
Exhibits 125: AbbVie Inc. - Overview
Exhibits 126: AbbVie Inc. - Product/Service
Exhibits 127: AbbVie Inc. - Key news
Exhibits 128: AbbVie Inc. - Key offerings
Exhibits 129: Achilles Therapeutics plc - Overview
Exhibits 130: Achilles Therapeutics plc - Product/Service
Exhibits 131: Achilles Therapeutics plc - Key offerings
Exhibits 132: AstraZeneca Plc - Overview
Exhibits 133: AstraZeneca Plc - Product/Service
Exhibits 134: AstraZeneca Plc - Key news
Exhibits 135: AstraZeneca Plc - Key offerings
Exhibits 136: Bayer AG - Overview
Exhibits 137: Bayer AG - Business segments
Exhibits 138: Bayer AG - Key news
Exhibits 139: Bayer AG - Key offerings
Exhibits 140: Bayer AG - Segment focus
Exhibits 141: Bristol Myers Squibb Co. - Overview
Exhibits 142: Bristol Myers Squibb Co. - Product/Service
Exhibits 143: Bristol Myers Squibb Co. - Key news
Exhibits 144: Bristol Myers Squibb Co. - Key offerings
Exhibits 145: F. Hoffmann La Roche Ltd. - Overview
Exhibits 146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 147: F. Hoffmann La Roche Ltd. - Key news
Exhibits 148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 150: Gilead Sciences Inc. - Overview
Exhibits 151: Gilead Sciences Inc. - Product/Service
Exhibits 152: Gilead Sciences Inc. - Key news
Exhibits 153: Gilead Sciences Inc. - Key offerings
Exhibits 154: GlaxoSmithKline Plc - Overview
Exhibits 155: GlaxoSmithKline Plc - Business segments
Exhibits 156: GlaxoSmithKline Plc - Key offerings
Exhibits 157: GlaxoSmithKline Plc - Segment focus
Exhibits 158: Johnson and Johnson - Overview
Exhibits 159: Johnson and Johnson - Business segments
Exhibits 160: Johnson and Johnson - Key news
Exhibits 161: Johnson and Johnson - Key offerings
Exhibits 162: Johnson and Johnson - Segment focus
Exhibits 163: Merck and Co. Inc. - Overview
Exhibits 164: Merck and Co. Inc. - Business segments
Exhibits 165: Merck and Co. Inc. - Key news
Exhibits 166: Merck and Co. Inc. - Key offerings
Exhibits 167: Merck and Co. Inc. - Segment focus
Exhibits 168: Novartis AG - Overview
Exhibits 169: Novartis AG - Business segments
Exhibits 170: Novartis AG - Key offerings
Exhibits 171: Novartis AG - Segment focus
Exhibits 172: Pfizer Inc. - Overview
Exhibits 173: Pfizer Inc. - Product/Service
Exhibits 174: Pfizer Inc. - Key news
Exhibits 175: Pfizer Inc. - Key offerings
Exhibits 176: Sanofi SA - Overview
Exhibits 177: Sanofi SA - Business segments
Exhibits 178: Sanofi SA - Key news
Exhibits 179: Sanofi SA - Key offerings
Exhibits 180: Sanofi SA - Segment focus
Exhibits 181: Viatris Inc. - Overview
Exhibits 182: Viatris Inc. - Business segments
Exhibits 183: Viatris Inc. - Key offerings
Exhibits 184: Viatris Inc. - Segment focus
Exhibits 185: Inclusions checklist
Exhibits 186: Exclusions checklist
Exhibits 187: Currency conversion rates for US$
Exhibits 188: Research methodology
Exhibits 189: Validation techniques employed for market sizing
Exhibits 190: Information sources
Exhibits 191: List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global hospital infection therapeutics market: Abbott Laboratories, AbbVie Inc., Achilles Therapeutics plc, AstraZeneca Plc, Basilea Pharmaceutica Ltd., Bayer AG, Bristol Myers Squibb Co., Cipla Ltd., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Spero Therapeutics Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing hospital visits.`
According to the report, one of the major drivers for this market is the increase in the incidence and prevalence of respiratory disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Achilles Therapeutics plc
- AstraZeneca Plc
- Basilea Pharmaceutica Ltd.
- Bayer AG
- Bristol Myers Squibb Co.
- Cipla Ltd.
- F. Hoffmann La Roche Ltd.
- Gilead Sciences Inc.
- GlaxoSmithKline Plc
- Johnson and Johnson
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Spero Therapeutics Inc.
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
